Genenta Science S.p.A.
GNTA
$3.84
-$0.0867-2.21%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -14.87% | -12.85% | -21.42% | -19.44% | 17.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.30% | -32.74% | -24.56% | -22.66% | 67.29% |
| Operating Income | 34.30% | 32.74% | 24.56% | 22.66% | -67.29% |
| Income Before Tax | 40.92% | 39.52% | 19.12% | 17.08% | -227.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 40.92% | 39.52% | 19.12% | 17.08% | -227.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.92% | 39.52% | 19.12% | 17.08% | -227.02% |
| EBIT | 34.30% | 32.74% | 24.56% | 22.66% | -67.29% |
| EBITDA | 34.42% | 32.86% | 24.85% | 22.96% | -66.89% |
| EPS Basic | 41.06% | 39.65% | 19.10% | 17.05% | -226.70% |
| Normalized Basic EPS | 41.05% | 39.66% | 19.18% | 17.09% | -226.94% |
| EPS Diluted | 41.06% | 39.65% | 19.10% | 17.05% | -226.70% |
| Normalized Diluted EPS | 41.05% | 39.66% | 19.18% | 17.09% | -226.94% |
| Average Basic Shares Outstanding | 0.22% | 0.22% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.22% | 0.22% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
